13.1 C
London

Tom Harrington

Westminster correspondent

PharmaCyte Biotech Increases Stake in TNF Pharmaceuticals Around LightSolver License

PharmaCyte Biotech increases stake in TNF Pharmaceuticals, bolstering the licensing of LightSolver’s light‑based compute accelerator in cryptocurrency and blockchain applications. PharmaCyte reported over USD 55 million in total assets as of April 30, 2025 and is actively pursuing broader investment...

João Pessoa: The New Growth Frontier for Global Real Estate

When Established Markets Plateau London, New York, Dubai: the major capitals of international real estate are showing declining yields and prohibitive prices. Global investors are now turning to intermediate markets, still affordable, yet already displaying strong signs of sustainable growth. A...

Somnigroup Acquires Stake in Fullpower-AI, Securing Long-Term Rights to AI Sleep Platform

Somnigroup acquires stake in Fullpower-AI through a $25 million equity transaction, solidifying its long-standing partnership with the biosensing AI solutions provider. The strategic acquisition, disclosed on 7 August 2025, grants Somnigroup a 15.6% ownership interest and secures exclusive commercial...

Geospace Technologies Secures Heartbeat Detector® to Expand Perimeter Security Capabilities

Geospace Technologies Heartbeat Detector strategically enhances the company’s portfolio, traditionally rooted in seismic sensors and rugged industrial instruments. With the full acquisition of Heartbeat Detector® on 31 July 2025, the Texas-based firm continues its expansion into high-growth, recurring-revenue sectors. Originally...

AI-Powered Commerce Toolkit: Vertiqal Studios and Revmo Redefine Brand Strategy on Social Media

A Strategic Shift in Digital Advertising The AI-Powered Commerce Toolkit, the latest innovation from Vertiqal Studios in collaboration with data intelligence firm Revmo, could soon become a cornerstone of modern digital strategy. With the rise of social commerce, this proprietary...

VitaGuard™ Strategic Alliance Revolutionizes Precision Oncology in Southeast Asia

VitaGuard™ Precision Oncology partnership ushers in a breakthrough in cancer diagnostics. BioNexus Gene Lab Corp. has entered a strategic cross‑equity alliance with Singapore’s Fidelion Diagnostics to commercialise VitaGuard™ across ASEAN. VitaGuard™ Precision Oncology Alliance: A Landmark Deal BGLC will acquire a...
spot_img

latest articles